TR199801614T2 - Peptit türevleri - Google Patents

Peptit türevleri

Info

Publication number
TR199801614T2
TR199801614T2 TR1998/01614T TR9801614T TR199801614T2 TR 199801614 T2 TR199801614 T2 TR 199801614T2 TR 1998/01614 T TR1998/01614 T TR 1998/01614T TR 9801614 T TR9801614 T TR 9801614T TR 199801614 T2 TR199801614 T2 TR 199801614T2
Authority
TR
Turkey
Prior art keywords
peptide derivatives
useful
new peptide
linked
compounds
Prior art date
Application number
TR1998/01614T
Other languages
English (en)
Inventor
Cotton Ronald
Neil Edwards Philip
William Arthur Luke Richard
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603855.9A external-priority patent/GB9603855D0/en
Priority claimed from GBGB9620819.4A external-priority patent/GB9620819D0/en
Application filed by Zeneca Limited filed Critical Zeneca Limited
Publication of TR199801614T2 publication Critical patent/TR199801614T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bulus P, R1, R2, R3 ve R4'ün burada tanimlanan çesitli anlamlari tasidigi formül (I): P-R1-R2-R3-R4'ü haiz farmasötik olarak yararli peptid türevlerine ve farmasötik olarak kabul edilebilir tuzlarina ve bunlari içeren farmasötik bilesimlere iliskindir. Yeni peptid türevleri romatizmal artrit gibi MHC sinif II bagli T-hücresi dolayimli otoimmün veya enflamatuar hastaliklarin tedavisinde yararlidir. Bulus ayrica yeni peptit türevlerinin imalati için islemlere ve bilesiklerin tibbi tedavide kullanimina iliskindir
TR1998/01614T 1996-02-23 1997-02-18 Peptit türevleri TR199801614T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603855.9A GB9603855D0 (en) 1996-02-23 1996-02-23 Peptide derivatives
GBGB9620819.4A GB9620819D0 (en) 1996-10-05 1996-10-05 Chemical compounds

Publications (1)

Publication Number Publication Date
TR199801614T2 true TR199801614T2 (tr) 1998-11-23

Family

ID=26308795

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01614T TR199801614T2 (tr) 1996-02-23 1997-02-18 Peptit türevleri

Country Status (29)

Country Link
US (1) US6087336A (tr)
EP (1) EP0882066B1 (tr)
JP (1) JP3468528B2 (tr)
KR (1) KR19990087123A (tr)
CN (1) CN1116305C (tr)
AR (1) AR005974A1 (tr)
AT (1) ATE196152T1 (tr)
AU (1) AU722877C (tr)
BR (1) BR9707720A (tr)
CA (1) CA2242809A1 (tr)
CZ (1) CZ266398A3 (tr)
DE (1) DE69703032T2 (tr)
DK (1) DK0882066T3 (tr)
ES (1) ES2151716T3 (tr)
GB (1) GB9702377D0 (tr)
GR (1) GR3034361T3 (tr)
HK (1) HK1015383A1 (tr)
HR (1) HRP970099B1 (tr)
HU (1) HU222198B1 (tr)
ID (1) ID16037A (tr)
IL (1) IL125804A0 (tr)
NO (1) NO983849L (tr)
NZ (1) NZ330944A (tr)
PL (1) PL328486A1 (tr)
PT (1) PT882066E (tr)
SK (1) SK114998A3 (tr)
TR (1) TR199801614T2 (tr)
TW (1) TW492978B (tr)
WO (1) WO1997031023A1 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
CN1130372C (zh) * 1996-06-07 2003-12-10 曾尼卡有限公司 肽衍生物
GB9621836D0 (en) * 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) * 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
GB9625865D0 (en) * 1996-12-12 1997-01-29 Zeneca Ltd Peptides
GB9809021D0 (en) 1998-04-29 1998-06-24 Zeneca Ltd Chemical process
US6262080B1 (en) 1998-12-31 2001-07-17 Avantis Pharmaceuticals Inc. 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase
ATE233259T1 (de) * 1998-12-31 2003-03-15 Aventis Pharma Inc 3-(thio-substituierte amido)-lactame, verwendbar als inhibitoren der matrix-metalloproteinase
GB9912911D0 (en) * 1999-06-04 1999-08-04 Zeneca Ltd Chemical process
US6485740B1 (en) * 2000-03-14 2002-11-26 Yutoku Pharmaceutical Ind., Co., Ltd. Transdermal methotrexate preparations
GB0017979D0 (en) * 2000-07-22 2000-09-13 Astrazeneca Ab Chemical process
GB0130285D0 (en) 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0317733D0 (en) 2003-07-29 2003-09-03 Novartis Ag Organic compounds
EP2366448B1 (en) * 2010-03-16 2016-07-27 Amminex Emissions Technology A/S Method and device for controlled dosing of a gas with fluctuating supply pressure

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) * 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
US4680283A (en) * 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
DE3711335A1 (de) * 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5331089A (en) * 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
AU8305491A (en) * 1990-08-01 1992-03-02 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
WO1993005011A1 (en) * 1991-08-29 1993-03-18 Sandoz Ltd. Novel immunosuppressants
EP0644197B1 (en) * 1993-06-04 1998-09-09 Vertex Pharmaceuticals Incorporated Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors
CN1135181A (zh) * 1993-09-14 1996-11-06 Cytel有限公司 使用泛dr结合肽改变免疫应答
CA2186873A1 (en) * 1994-04-01 1995-10-12 Charles J. Hackett Haptenated peptides and uses thereof
CA2215720A1 (en) * 1995-03-24 1996-10-03 Molecumetics, Ltd. .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
WO1997016425A1 (en) * 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5719296A (en) * 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
ATE196152T1 (de) 2000-09-15
NZ330944A (en) 2000-04-28
PL328486A1 (en) 1999-02-01
CZ266398A3 (cs) 1998-11-11
NO983849L (no) 1998-10-21
HK1015383A1 (en) 1999-10-15
ID16037A (id) 1997-08-28
DE69703032D1 (de) 2000-10-12
WO1997031023A1 (en) 1997-08-28
EP0882066A1 (en) 1998-12-09
HRP970099B1 (en) 2001-10-31
AR005974A1 (es) 1999-07-21
CA2242809A1 (en) 1997-08-28
PT882066E (pt) 2000-12-29
ES2151716T3 (es) 2001-01-01
HRP970099A2 (en) 1998-04-30
HU222198B1 (hu) 2003-05-28
GR3034361T3 (en) 2000-12-29
GB9702377D0 (en) 1997-03-26
TW492978B (en) 2002-07-01
NO983849D0 (no) 1998-08-21
AU1803597A (en) 1997-09-10
AU722877C (en) 2002-12-05
BR9707720A (pt) 1999-04-06
EP0882066B1 (en) 2000-09-06
IL125804A0 (en) 1999-04-11
DK0882066T3 (da) 2000-12-18
AU722877B2 (en) 2000-08-10
US6087336A (en) 2000-07-11
CN1116305C (zh) 2003-07-30
JP3468528B2 (ja) 2003-11-17
HUP9901189A3 (en) 2000-07-28
CN1213379A (zh) 1999-04-07
KR19990087123A (ko) 1999-12-15
JP2000508623A (ja) 2000-07-11
SK114998A3 (en) 1999-02-11
HUP9901189A2 (hu) 1999-08-30
DE69703032T2 (de) 2001-04-12

Similar Documents

Publication Publication Date Title
SE9902987D0 (sv) Novel compounds
TR199802537T2 (tr) Peptit türevleri.
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
PT1263725E (pt) Novos compostos
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
SE9604786D0 (sv) New compounds
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
TR199801614T2 (tr) Peptit türevleri
TR199901417T2 (tr) Analjezik etkisi olan yeni bilesimler.
GB9813540D0 (en) Chemical compounds
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
AP9701041A0 (en) Pyridylpyrrole compounds.
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
BG101118A (en) Therapeutical compounds
TR200000289T2 (tr) Kimyasal bileşimler
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
NO304889B1 (no) Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
PT705100E (pt) Guanidinas substituidas terapeuticas
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
EE03262B1 (et) Imidaso[1,2-a]püridiinidest saadavad alkoksüalküülkarbamaadid, nende valmistamine ja kasutamine
SE9902765D0 (sv) Novel compounds
BG106155A (en) Novel derivatives and analogues of galanthamin